Turn Therapeutics enters global supply, development, and license agreement with Medline

Turn Therapeutics Inc.

Agreement covers development, manufacture, and commercialization of products using Turn's PermaFusion delivery platform.
Medline is the largest provider of medical-surgical products and supply chain solutions in the U.S.
Financial terms, product categories, and development timelines remain confidential per agreement terms.
CEO Bradley Burnam calls partnership a 'transformative milestone' to accelerate entry into professional and consumer markets.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.